Tag: ATH

spot_imgspot_img

Alterity Therapeutics: Receives $640k grant from Michael J. Fox Foundation

Alterity Therapeutics (ATH) has received a US$495,000 (around A$640,428) grant from The Michael J. Fox Foundation for Parkinson's Research The grant allows Alterity...

Alterity Therapeutics: Appoints Dr David Stamler as CEO

Alterity Therapeutics (ATH) has appointed Dr. David Stamler as CEO, effective immediately Dr. Stamler has been with the company since June 2017, previously...